Pasireotide-d7 (TFA)

Pasireotide-d7 (TFA)

• UNSPSC Description: Pasireotide-d7 (TFA) is the deuterium labeled Pasireotide TFA[1].
• Target Antigen: Isotope-Labeled Compounds
• Type: Isotope-Labeled Compounds
• Related Pathways: Others
• Field of Research: Others
• Solubility: 10 mM in DMSO
• Smiles: OC(C(F)(F)F)=O.O=C1N2[C@@](C(N[C@](C3=CC=CC=C3)([H])C(N[C@@H](C(N[C@H](C(N[C@H](C(N[C@H]1CC4=CC=CC=C4)=O)CC5=CC=C(C=C5)OC([2H])([2H])C6=C([2H])C([2H])=C([2H])C([2H])=C6[2H])=O)CCCCN)=O)CC7=CNC8=CC=CC=C78)=O)=O)([H])C[C@H](C2)OC(NCCN)=O.[3]
• Molecular Weight: 1396.31
• References & Citations: [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported